“We are particularly encouraged by the decision to categorise aesthetic procedures according to their clinical risk under a tiered ‘red, amber, green’ framework,” says Dr Stephen Hannan, clinical director at sk:n, a leading network of CQC-registered skin and aesthetics clinics throughout the UK.
“Treatments involving injectable substances such as botulinum toxin – which fall under the higher-risk red category – must be subject to stringent regulation.
“We strongly support the Government’s intention to require that such procedures only take place in CQC-registered premises under the direction of qualified medical professionals.
“This new framework has the potential to protect patients and uphold professional standards — but only if implementation is timely and enforcement is robust.”
Next steps
The new regulations will be subject to public consultation and parliamentary scrutiny before they are introduced.
The government’s commitment follows a consultation launched in September 2023, which received almost 12,000 responses. This was the first consultation on proposals for strengthening regulation in this space.
Sign up here to receive our weekly news delivered direct to your inbox